The U.S. Food and Drug Administration is utilizing a statistical data mining method within its Sentinel distributed database to identify previously unknown safety concerns associated with mifepristone

From the articleDA Says It Won't Act On Abortion Drugs Till March, 2 Years After Pledging To Review Safety ConcernsAlso in FDA says its safety review of abortion pill will continue into next year | CNN, FDA says its review of abortion pill will continue into next year, FDA says its review of abortion pill will continue into next year